Filing Details
- Accession Number:
- 0000899243-19-012935
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-09 20:04:48
- Reporting Period:
- 2019-05-07
- Accepted Time:
- 2019-05-09 20:04:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1351288 | Gw Pharmaceuticals Plc | GWPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1754239 | D. Adam George | Sovereign House, Vision Park, Histon Cambridge X0 CB24 9BZ | Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2019-05-07 | 258,324 | $0.00 | 268,324 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2019-05-07 | 258,324 | $16.10 | 10,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Stock Options | Disposition | 2019-05-07 | 31,144 | $0.00 | 31,144 | $0.00 |
Ordinary Shares | Stock Options | Disposition | 2019-05-07 | 39,121 | $0.00 | 39,121 | $0.00 |
Ordinary Shares | Stock Options | Disposition | 2019-05-07 | 46,071 | $0.00 | 46,071 | $0.00 |
Ordinary Shares | Stock Options | Disposition | 2019-05-07 | 59,128 | $0.00 | 59,128 | $0.00 |
Ordinary Shares | Stock Options | Disposition | 2019-05-07 | 69,924 | $0.00 | 69,924 | $0.00 |
Ordinary Shares | Stock Options | Disposition | 2019-05-07 | 12,936 | $0.00 | 12,936 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2020-07-19 | No | 4 | M | Direct | |
0 | 2023-09-24 | No | 4 | M | Direct | |
0 | 2024-08-12 | No | 4 | M | Direct | |
3,620 | 2025-06-24 | No | 4 | M | Direct | |
97,018 | 2026-02-15 | No | 4 | M | Direct | |
99,180 | 2027-01-06 | No | 4 | M | Direct |
Footnotes
- Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
- Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of May 7, 2019.
- Represented by ADSs. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2019.
- The exercise price reported is price per ordinary share converted from price per ADS.
- Granted pursuant to the Issuer's Enterprise Management Incentive Scheme and fully vested.
- Granted pursuant to the Issuer's Long-Term Incentive Plan and fully vested.
- Granted pursuant to the Issuer's Long-Term Incentive Plan, of which 3,620 shares will vest on June 24, 2019 and the rest have vested.
- Granted pursuant to the Issuer's Long-Term Incentive Plan, of which 9,632 shares will vest on February 15, 2020, and the rest have vested.
- Granted pursuant to the Issuer's Long-Term Incentive Plan, of which 92,712 shares will vest on January 6, 2020, 6,468 shares will vest on January 6, 2021 and the rest have vested